Tecogen Announces Third Quarter 2023 Results
- Increased revenue for Q3 2023 compared to the same period in 2022.
- Positive progress in marketing efforts and product margin increase.
- Decline in inventory levels and establishment of a $1.5 million credit facility to improve liquidity.
- Exploration of opportunities to accelerate customer decision-making regarding energy projects.
- Decrease in product revenue and net loss increase due to higher operating expenses.
- Decrease in energy production revenue for the nine months ended September 30, 2023 compared to the same period in 2022.
- Loss from operations increased due to lower revenue and gross profit margins in the Products segment.
Q3 2023 Revenue of
WALTHAM, MA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Tecogen Inc. (OTCQX:TGEN), a leading manufacturer of clean energy products, reported revenues of
"We continue to make progress towards the objectives we set out earlier in the year. We have seen revenue increase this quarter both compared to earlier this year and to the same period last year. We have focused our marketing efforts on finding project developers for our clean cooling solutions, especially in locations that are more favorable to gas technologies. This is leading to an increase in the size of our sales pipeline and I'm cautiously optimistic that we will receive customer orders for many of these projects over the upcoming few months.
“We also saw an increase in product margin due to increased pricing and the product mix this quarter. We expect service margin to recover to greater than
“As we work to strengthen our balance sheet, I am pleased to see a decline in inventory levels compared to earlier in the year. We established a
“Lastly, the air-cooled chiller testing is progressing and we are working on getting this product specified on customer projects and obtaining purchase orders," commented Abinand Rangesh, Tecogen's Chief Executive Officer.
Key Takeaways
Revenues
- Revenues for Q3 2023 were
$7.1 million compared to$6.6 million for the same period in 2022, a7.5% increase.- Products revenue was
$2.9 million in Q3 2023 compared to$3.2 million in the same period in 2022, a decrease of8.4% , primarily due to decreased cogeneration sales which was offset partially by higher chiller sales into our key market segments including controlled environment agriculture. - Services revenue was
$3.8 million in Q3 2023 compared to$3.1 million in the same period in 2022, an increase of24.8% , primarily due to revenue from the acquired Aegis maintenance contracts and a5.2% increase in revenue from existing contracts. - Energy Production revenue decreased
0.5% , to$331 thousand in Q3 2023 compared to$333 thousand in the same period in 2022.
- Products revenue was
- Revenues for the nine months ended September 30, 2023 were
$19.2 million compared to$20.5 million for the same period in 2022, a6.0% decrease.- Products revenue was
$7.1 million in the nine months ended September 30, 2023 compared to$10.2 million in the same period in 2022, a decrease of30.1% , primarily due to decreased cogeneration and chiller sales into our key market segments including controlled environment agriculture. - Services revenue was
$10.9 million in the nine months ended September 30, 2023 compared to$9.0 million in the same period in 2022, an increase of20.8% , primarily due to revenue from the acquired Aegis maintenance contracts and a7.3% increase in revenue from existing contracts. - Energy Production revenue decreased
4.2% , to$1.21 million in the nine months ended September 30, 2023 compared to$1.27 million in the same period in 2022 due to temporary maintenance work on two sites.
- Products revenue was
Net Loss and Earnings Per Share
- Net loss in Q3 2023 was
$0.5 million compared to net loss of$0.3 million in Q3 2022, an increase of$0.2 million , primarily due to increased operating expenses. EPS was a net loss of$0.02 /share and a net loss of$0.01 in Q3 2023 and Q3 2022, respectively. - Net loss for the nine months ended September 30, 2023 was
$2.8 million compared to net loss of$1.0 million in the comparable 2022 period, an increase of$1.7 million , due primarily to lower Products segment revenue and gross profit and an increase in operating expenses. EPS was a net loss of$0.11 /share and a net loss of$0.04 /share in the nine months ended September 30, 2023 and 2022, respectively.
Loss from Operations
- Loss from operations for Q3 2023 increased to
$0.4 million compared to a loss of$0.2 million for the same period in 2022 due to higher operating expenses. - Loss from operations for the nine months ended September 30, 2023 was
$2.6 million compared to a loss of$1.0 million for the same period in 2022, an increase of$1.6 million . The loss from operations increased due to lower revenue and gross profit margins in our Products segment and increased operating expenses.
Gross Profit and Gross Margin
- Gross profit for Q3 2023 was
$2.9 million compared to$2.9 million in the third quarter of 2022. Gross margin was41.1% in Q3 2023 quarter compared to43.7% for the same period in 2022. Products margin increased to43.2% from35.3% , due to price increases instituted in 2023, while Services margin decreased to38.9% from51.8% , due to higher labor and material costs. In particular, as supply chain constraints for engines eased, we performed significant engine related replacements and upgrades which negatively impacted Service margins. Energy Production margin decreased to48.5% in Q3 2023 from49.5% for the same period in 2022. - Gross profit for the nine months ended September 30, 2023 decreased to
$7.9 million compared to$8.7 million in the same period in 2022, a decrease of$0.8 million . Gross margin decreased to40.8% in the nine months ended September 30, 2023 compared to42.4% for the same period in 2022. Products margin increased to36.6% from33.7% , due to price increases instituted in 2023, and Services margin decreased to43.7% from52.2% , due to higher labor and material costs. In particular, as supply chain constraints for engines eased, we performed a significant number of engine replacements in the nine months ended September 30, 2023 which negatively impacted Service margins. Energy Production margin deceased to40.1% from42.7% due to decreased runtime at the sites.
Operating Expenses
- Operating expenses increased by
6.0% to$3.3 million in Q3 2023 compared to$3.1 million in the same period in 2022 due primarily to an increase in bad debt expense, due to a customer accounts receivable settlement achieved in 2022, and increases in depreciation and amortization, travel, and business insurance, which are attributable in part to the Aegis acquisition. - Operating expenses increased by
8.4% to$10.5 million for the nine months ended September 30, 2023 compared to$9.6 million in the same period in 2022 due primarily to an increase in bad debt expense, due to a customer accounts receivable settlement achieved in 2022, and increases in depreciation and amortization, travel, and business insurance, which are attributable in part to the Aegis acquisition and increased consulting costs.
Adjusted EBITDA(1) was negative
Conference Call Scheduled for November 9, 2023, at 9:30 am ET
Tecogen will host a conference call on November 9, 2023 to discuss the third quarter results beginning at 9:30 AM eastern time. To listen to the call please dial (877) 407-7186 within the U.S. and Canada, or (201) 689-8052 from other international locations. Participants should ask to be joined to the Tecogen Third Quarter 2023 earnings call. Please begin dialing 10 minutes before the scheduled starting time. The earnings press release will be available on the Company website at www.Tecogen.com in the "News and Events" section under "About Us." The earnings conference call will be webcast live. To view the associated slides, register for and listen to the webcast, go to https://ir.tecogen.com/ir-calendar. Following the call, the recording will be archived for 14 days.
The earnings conference call will be recorded and available for playback one hour after the end of the call. To listen to the playback, dial (877) 660-6853 within the U.S. and Canada, or (201) 612-7415 from other international locations and use Conference Call ID#: 13672659.
About Tecogen
Tecogen Inc. designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer’s carbon footprint.
In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel across the United States. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.
Tecogen, InVerde e+, Ilios, Tecochill, Tecopower, Tecofrost, Tecopack, and Ultera are registered or pending trademarks of Tecogen Inc.
Forward Looking Statements
This press release and any accompanying documents, contain “forward-looking statements” which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures, that may include words such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "project," "target," "potential," "will," "should," "could," "likely," or "may" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.
In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and on our Form 8-K, under “Risk Factors”, among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.
In addition to GAAP financial measures, this press release includes certain non-GAAP financial measures, including adjusted EBITDA which excludes certain expenses as described in the presentation. We use Adjusted EBITDA as an internal measure of business operating performance and believe that the presentation of non-GAAP financial measures provides a meaningful perspective of the underlying operating performance of our current business and enables investors to better understand and evaluate our historical and prospective operating performance by eliminating items that vary from period to period without correlation to our core operating performance and highlights trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures.
Tecogen Media & Investor Relations Contact Information:
Abinand Rangesh
P: 781-466-6487
E: Abinand.Rangesh@tecogen.com
TECOGEN INC
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
September 30, 2023 | December 31, 2022 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 646,161 | $ | 1,913,969 | |||
Accounts receivable, net | 7,694,571 | 6,714,122 | |||||
Unbilled revenue | 1,748,336 | 1,805,330 | |||||
Employee retention credit receivable | 46,148 | 713,269 | |||||
Inventories, net | 11,039,313 | 10,482,729 | |||||
Prepaid and other current assets | 420,317 | 401,189 | |||||
Total current assets | 21,594,846 | 22,030,608 | |||||
Long-term assets: | |||||||
Property, plant and equipment, net | 1,254,656 | 1,407,720 | |||||
Right of use assets | 754,957 | 1,245,549 | |||||
Intangible assets, net | 2,307,902 | 997,594 | |||||
Goodwill | 3,129,147 | 2,406,156 | |||||
Other assets | 145,237 | 165,230 | |||||
TOTAL ASSETS | $ | 29,186,745 | $ | 28,252,857 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 4,493,758 | $ | 3,261,952 | |||
Accrued expenses | 2,632,607 | 2,384,447 | |||||
Deferred revenue, current | 1,655,737 | 1,115,627 | |||||
Lease obligations, current | 367,938 | 687,589 | |||||
Acquisition liabilities, current | 775,991 | — | |||||
Unfavorable contract liability, current | 201,090 | 236,705 | |||||
Total current liabilities | 10,127,121 | 7,686,320 | |||||
Long-term liabilities: | |||||||
Deferred revenue, net of current portion | 290,226 | 371,823 | |||||
Lease obligations, net of current portion | 429,737 | 623,452 | |||||
Acquisition liabilities, net of current portion | 1,485,677 | — | |||||
Unfavorable contract liability, net of current portion | 448,695 | 583,512 | |||||
Total liabilities | 12,781,456 | 9,265,107 | |||||
Stockholders’ equity: | |||||||
Tecogen Inc. shareholders’ equity: | |||||||
Common stock, | 24,850 | 24,850 | |||||
Additional paid-in capital | 57,525,719 | 57,351,008 | |||||
Accumulated deficit | (41,033,259) | (38,281,548) | |||||
Total Tecogen Inc. stockholders’ equity | 16,517,310 | 19,094,310 | |||||
Non-controlling interest | (112,021) | (106,560) | |||||
Total stockholders’ equity | 16,405,289 | 18,987,750 | |||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 29,186,745 | $ | 28,252,857 |
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
Three Months Ended | |||||||
September 30, 2023 | September 30, 2022 | ||||||
Revenues | |||||||
Products | $ | 2,938,789 | $ | 3,206,732 | |||
Services | 3,842,600 | 3,078,604 | |||||
Energy production | 331,141 | 332,774 | |||||
Total revenues | 7,112,530 | 6,618,110 | |||||
Cost of sales | |||||||
Products | 1,669,747 | 2,074,243 | |||||
Services | 2,346,384 | 1,482,355 | |||||
Energy production | 170,378 | 168,178 | |||||
Total cost of sales | 4,186,509 | 3,724,776 | |||||
Gross profit | 2,926,021 | 2,893,334 | |||||
Operating expenses | |||||||
General and administrative | 2,708,817 | 2,343,449 | |||||
Selling | 425,465 | 567,529 | |||||
Research and Development | 160,033 | 202,138 | |||||
Gain on disposition of assets | — | (5,486 | ) | ||||
Total operating expenses | 3,294,315 | 3,107,630 | |||||
Loss from operations | (368,294 | ) | (214,296 | ) | |||
Other income (expense) | |||||||
Interest and other income expense, net | (16,330 | ) | (7,140 | ) | |||
Interest expense | (6,357 | ) | (2,280 | ) | |||
Unrealized loss on investment securities | (56,246 | ) | — | ||||
Total other income (expense), net | (78,933 | ) | (9,420 | ) | |||
Loss before provision for state income taxes | (447,227 | ) | (223,716 | ) | |||
Provision for state income taxes | — | 5,922 | |||||
Consolidated net loss | (447,227 | ) | (229,638 | ) | |||
Income attributable to the non-controlling interest | (34,346 | ) | (27,074 | ) | |||
Net loss attributable to Tecogen Inc. | $ | (481,573 | ) | $ | (256,712 | ) | |
Net loss per share - basic | $ | (0.02 | ) | $ | (0.01 | ) | |
Net loss per share - diluted | $ | (0.02 | ) | $ | (0.01 | ) | |
Weighted average shares outstanding - basic | 24,850,261 | 24,850,261 | |||||
Weighted average shares outstanding - diluted | 24,850,261 | 24,850,261 |
Three Months Ended | |||||||
September 30, 2023 | September 30, 2022 | ||||||
Non-GAAP financial disclosure (1) | |||||||
Net loss attributable to Tecogen Inc. | $ | (481,573 | ) | $ | (256,712 | ) | |
Interest expense, net | 6,357 | 2,280 | |||||
Income taxes | — | 5,922 | |||||
Depreciation & amortization, net | 168,684 | 107,250 | |||||
EBITDA | (306,532 | ) | (141,260 | ) | |||
Stock-based compensation | 68,775 | 69,118 | |||||
Unrealized loss on investment securities | 56,246 | — | |||||
Adjusted EBITDA | $ | (181,511 | ) | $ | (72,142 | ) |
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
Nine Months Ended | |||||||
September 30, 2023 | September 30, 2022 | ||||||
Revenues | |||||||
Products | $ | 7,094,556 | $ | 10,156,328 | |||
Services | 10,931,744 | 9,046,075 | |||||
Energy production | 1,214,806 | 1,268,623 | |||||
Total revenues | 19,241,106 | 20,471,026 | |||||
Cost of sales | |||||||
Products | 4,500,771 | 6,734,465 | |||||
Services | 6,159,855 | 4,322,693 | |||||
Energy production | 728,124 | 726,297 | |||||
Total cost of sales | 11,388,750 | 11,783,455 | |||||
Gross profit | 7,852,356 | 8,687,571 | |||||
Operating expenses | |||||||
General and administrative | 8,418,581 | 7,642,183 | |||||
Selling | 1,426,321 | 1,572,221 | |||||
Research and development | 625,691 | 537,126 | |||||
Gain on disposition of assets | (19,950 | ) | (41,931 | ) | |||
Gain on termination of unfavorable contract liability | — | (71,375 | ) | ||||
Total operating expenses | 10,450,643 | 9,638,224 | |||||
Loss from operations | (2,598,287 | ) | (950,653 | ) | |||
Other income (expense) | |||||||
Interest and other expense, net | (36,562 | ) | (22,556 | ) | |||
Interest expense | (8,629 | ) | (15,841 | ) | |||
Unrealized gain (loss) on investment securities | (18,749 | ) | 37,497 | ||||
Total other income (expense), net | (63,940 | ) | (900 | ) | |||
Loss before provision for state income taxes | (2,662,227 | ) | (951,553 | ) | |||
Provision for state income taxes | 32,252 | 16,352 | |||||
Consolidated net loss | (2,694,479 | ) | (967,905 | ) | |||
Income attributable to non-controlling interest | (57,232 | ) | (55,616 | ) | |||
Net loss attributable to Tecogen Inc. | $ | (2,751,711 | ) | $ | (1,023,521 | ) | |
Net loss per share - basic | $ | (0.11 | ) | $ | (0.04 | ) | |
Net loss per share - diluted | $ | (0.11 | ) | $ | (0.04 | ) | |
Weighted average shares outstanding - basic | 24,850,261 | 24,850,261 | |||||
Weighted average shares outstanding - diluted | 24,850,261 | 24,850,261 |
Nine Months Ended | |||||||
September 30, 2023 | September 30, 2022 | ||||||
Non-GAAP financial disclosure (1) | |||||||
Net loss attributable to Tecogen Inc. | $ | (2,751,711 | ) | $ | (1,023,521 | ) | |
Interest expense, net | 8,629 | 15,841 | |||||
Income taxes | 32,252 | 16,352 | |||||
Depreciation & amortization, net | 459,779 | 324,968 | |||||
EBITDA | (2,251,051 | ) | (666,360 | ) | |||
Stock-based compensation | 174,711 | 254,718 | |||||
Unrealized (gain) loss on marketable securities | 18,749 | (37,497 | ) | ||||
Gain on termination of unfavorable contract liability | — | (71,375 | ) | ||||
Adjusted EBITDA | $ | (2,057,591 | ) | $ | (520,514 | ) |
(1) Non-GAAP Financial Measures
In addition to reporting net income, a U.S. generally accepted accounting principle (“GAAP”) measure, this news release contains information about Adjusted EBITDA (net income (loss) attributable to Tecogen Inc adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on investment securities, goodwill impairment charges and other non-cash non-recurring charges including abandonment of certain intangible assets and extinguishment of debt), which is a non-GAAP measure. The Company believes Adjusted EBITDA allows investors to view its performance in a manner similar to the methods used by management and provides additional insight into its operating results. Adjusted EBITDA is not calculated through the application of GAAP. Accordingly, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
Nine Months Ended | |||||||
September 30, 2023 | September 30, 2022 | ||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
Consolidated net loss | $ | (2,694,479 | ) | $ | (967,905 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization | 459,779 | 324,968 | |||||
Stock-based compensation | 174,711 | 254,718 | |||||
Provision (release) for doubtful accounts | 44,000 | (183,955 | ) | ||||
Gain on disposition of assets | (19,950 | ) | (41,931 | ) | |||
Unrealized (gain) loss on investment securities | 18,749 | (37,497 | ) | ||||
Gain on termination of unfavorable contract liability | — | (71,375 | ) | ||||
Changes in operating assets and liabilities | |||||||
(Increase) decrease in: | |||||||
Accounts receivable | (1,324,448 | ) | 67,940 | ||||
Employee retention credit receivable | 667,121 | 562,752 | |||||
Unbilled revenue | 56,994 | 1,302,187 | |||||
Inventories | (165,537 | ) | (947,031 | ) | |||
Prepaid assets and other current assets | (19,128 | ) | 70,806 | ||||
Other assets | 491,836 | 466,420 | |||||
Increase (decrease) in: | |||||||
Accounts payable | 1,140,759 | (182,903 | ) | ||||
Accrued expenses and other current liabilities | 256,847 | (80,720 | ) | ||||
Deferred revenue | 458,512 | (487,676 | ) | ||||
Other liabilities | (566,016 | ) | (482,608 | ) | |||
Net cash used in operating activities | (1,020,250 | ) | (433,810 | ) | |||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
Purchases of property and equipment | (31,728 | ) | (286,820 | ) | |||
Payment for business acquisition | (170,000 | ) | — | ||||
Purchases of intangible assets | — | (29,505 | ) | ||||
Proceeds from disposition of assets | 16,863 | 72,655 | |||||
Distributions to non-controlling interest | (62,693 | ) | (56,823 | ) | |||
Net cash used in investing activities | (247,558 | ) | (300,493 | ) | |||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
Net cash provided by financing activities | — | — | |||||
Change in cash and cash equivalents | (1,267,808 | ) | (734,303 | ) | |||
Cash and cash equivalents, beginning of the period | 1,913,969 | 3,614,463 | |||||
Cash and cash equivalents, end of the period | $ | 646,161 | $ | 2,880,160 | |||
Supplemental disclosures of cash flows information: | |||||||
Cash paid for interest | $ | 7,385 | $ | 14,597 | |||
Cash paid for taxes | $ | 32,252 | $ | 16,352 | |||
Non-cash consideration issued for Aegis acquisition: | |||||||
Accounts receivable credit | $ | 300,000 | $ | — | |||
Accounts payable assumed | 91,048 | — | |||||
Contingent consideration | 1,442,462 | — | |||||
Total fair value of non-cash consideration | $ | 1,833,510 | $ | — |
FAQ
What was Tecogen Inc.'s Q3 2023 revenue?
What were the key takeaways from the PR?
What financial figures were reported for the nine months ended September 30, 2023?